{
    "Trade/Device Name(s)": [
        "Liquichek Pediatric Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K130963",
    "Predicate Device Reference 510(k) Number(s)": [
        "K872227"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "April 02, 2013",
    "Summary Letter Received Date": "April 08, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Bilirubin, Direct",
        "Bilirubin, Total",
        "Caffeine",
        "Calcium",
        "Chloride",
        "Glucose",
        "Magnesium",
        "Potassium",
        "Sodium",
        "Theophylline"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Pediatric Control, a quality control serum for monitoring precision of laboratory testing procedures for multiple analytes",
    "Indications for Use Summary": "Intended for use as a quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert",
    "fda_folder": "Clinical Chemistry"
}